Evaluation of Asthma and Allergic Rhinitis Risks in Patients with Atopic Dermatitis Undergoing Treatment with Biologics and JAK Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials - Top-Institutions - MDSpire

Evaluation of Asthma and Allergic Rhinitis Risks in Patients with Atopic Dermatitis Undergoing Treatment with Biologics and JAK Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

  • By

  • Liling Zeng

  • Tong Zhou

  • Lishan Zhang

  • Mo Xian

  • Zheng Zhu

  • Jing Liu

  • Shiyan Fu

  • Hualian Luo

  • Jing Li

  • February 7, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Allergy and Immunology
    • Dermatology
    • Clinical Research

  • #2

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Dermatology
    • Allergy and Immunology
    • Translational Medicine

  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Dermatology
    • Allergy and Immunology
    • Clinical Epidemiology

  • #4

    Massachusetts General Hospital, Harvard Medical School
    Massachusetts General Hospital, Harvard Medical School

    Boston, MA

    Key Differentiators

    • Dermatology
    • Allergy and Immunology
    • Pharmacology

  • #5

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Dermatology
    • Allergy and Immunology
    • Clinical Trials

Original Source(s)

Evaluation of Asthma and Allergic Rhinitis Risks in Patients with Atopic Dermatitis Undergoing Treatment with Biologics and JAK Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

  • by Liling Zeng, Tong Zhou, Lishan Zhang, Mo Xian, Zheng Zhu, Jing Liu, Shiyan Fu, Hualian Luo, Jing Li

  • February 7, 2026

Related Content

Oral TYK2 Inhibition in Atopic Dermatitis

Phase 2 trial evaluated once-daily oral TYK2 inhibition in adults with moderate to severe AD.

Fabricated Citations Are Reaching Medical Journals

A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.

Rapid Itch Relief Seen with Nemolizumab

Researchers examined early itch and sleep outcomes with interleukin-31 pathway inhibition in atopic dermatitis and prurigo nodularis in phase 3 trial analyses.